1. Signaling Pathways
  2. Immunology/Inflammation
  3. Thrombopoietin Receptor

Thrombopoietin Receptor

Thrombopoietin (TPO) is the major regulator of megakaryocytopoiesis and platelet formation. The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs. Upon binding of thrombopoietin CD110 is dimerized and the JAK family of non-receptor tyrosine kinases, as well as the STAT family, the MAPK family, the adaptor protein Shc and the receptors themselves become tyrosine phosphorylated.

TPO binds to the thrombopoietin receptor (TPOr, also termed c-mpl) on platelets, megakaryocytes, and pluripotent stem cells leading to inhibition of apoptosis of stem cells and megakaryocytes; increased megakaryocyte number, size, and ploidy; increased rate of megakaryocyte maturation and platelet count; and decreased platelet threshold for activation by ADP and collagen.

Thrombopoietin Receptor 相关产品 (5):

Cat. No. Product Name Effect Purity
  • HY-15306
    Eltrombopag Agonist 99.82%
    Eltrombopag (SB-497115) 是一种血小板生成素 (TPO) 受体激动剂,治疗导致血小板减少的某些病症。
  • HY-13463
    Avatrombopag Agonist
    Avatrombopag (E5501; AKR-501; YM477) 是一种口服活性 TPO 受体激动剂,其 EC50 值为 3.3 nM,可用于治疗血小板减少症。
  • HY-19883
    Lusutrombopag Agonist 99.09%
    Lusutrombopag 是一种可口服的血小板生成素受体 (thrombopoietin receptor) 激动剂,用于治疗慢性肝病。
  • HY-15306A
    Eltrombopag Olamine Agonist 99.56%
    Eltrombopag Olamine (Eltrombopag diethanolamine salt) 是一种血小板生成素受体激动剂,用于治疗慢性免疫性血小板减少症的低血小板计数。
  • HY-100380
    TPO agonist 1 Agonist
    TPO agonist 1 是一种 TPO 激动剂,可用作血小板生成和巨核细胞生成的促进剂,以治疗血小板减少症。详细信息请参考专利文献 WO2008134338A1 中的化合物 TPO mimetic。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.